FR3018919B1 - METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF - Google Patents

METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF Download PDF

Info

Publication number
FR3018919B1
FR3018919B1 FR1452246A FR1452246A FR3018919B1 FR 3018919 B1 FR3018919 B1 FR 3018919B1 FR 1452246 A FR1452246 A FR 1452246A FR 1452246 A FR1452246 A FR 1452246A FR 3018919 B1 FR3018919 B1 FR 3018919B1
Authority
FR
France
Prior art keywords
screening
applications
erbb2 inhibitors
erbb2
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1452246A
Other languages
French (fr)
Other versions
FR3018919A1 (en
Inventor
Sandrine Bourdoulous
Camille Faure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris 5 Rene Descartes
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris 5 Rene Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris 5 Rene Descartes filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1452246A priority Critical patent/FR3018919B1/en
Publication of FR3018919A1 publication Critical patent/FR3018919A1/en
Application granted granted Critical
Publication of FR3018919B1 publication Critical patent/FR3018919B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
FR1452246A 2014-03-18 2014-03-18 METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF Expired - Fee Related FR3018919B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1452246A FR3018919B1 (en) 2014-03-18 2014-03-18 METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1452246 2014-03-18
FR1452246A FR3018919B1 (en) 2014-03-18 2014-03-18 METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF

Publications (2)

Publication Number Publication Date
FR3018919A1 FR3018919A1 (en) 2015-09-25
FR3018919B1 true FR3018919B1 (en) 2018-03-16

Family

ID=51483510

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1452246A Expired - Fee Related FR3018919B1 (en) 2014-03-18 2014-03-18 METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF

Country Status (1)

Country Link
FR (1) FR3018919B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019081608A1 (en) * 2017-10-24 2019-05-02 Université Paris Descartes Diagnosis and/or prognosis of her2-dependent cancer using moesin as a biomarker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
US9127077B2 (en) * 2009-09-23 2015-09-08 L'universite Paris Descartes Polypeptides and nucleic acids for treating ErbB2-dependent cancers

Also Published As

Publication number Publication date
FR3018919A1 (en) 2015-09-25

Similar Documents

Publication Publication Date Title
BR112016023105A2 (en) process and method scheduling
FR3020303B1 (en) METHOD AND INSTALLATION FOR AUTOMATIC PRETENSION OF AN OBJECT.
FR3018015B1 (en) AUTOMATED ACOUSTIC EQUALIZATION METHOD AND SYSTEM
HK1211122A1 (en) Method and system for processing periodic order information
FR3031641B1 (en) METHOD OF IDENTIFYING AN ENTITY
FR3043811B1 (en) METHOD OF IDENTIFYING AN ENTITY
FR3026214B1 (en) METHOD FOR MANAGING ALERTS
BR112017007790A2 (en) horticultural method and apparatus
FR3018284B1 (en) CARD INSTALLATION AND METHOD FOR STARTING SUCH INSTALLATION
FR3032989B1 (en) FORMING BANK AND METHOD OF PLACING A BANK
FR3019967B1 (en) IMPROVED OSTRECULTURE PROCESS
FR3024974B1 (en) AEROSTAT AND DEBALLASTAGE METHOD USED IN THIS AEROSTAT
FR3019310B1 (en) METHOD FOR GEO-LOCATION OF THE ENVIRONMENT OF A BEARER
FR3024775B1 (en) PROCESS FOR IDENTIFYING AND CHARACTERIZING POLYPEPTIDE COMPOUNDS
FR3016366B1 (en) SOLID BITUMEN AND METHOD FOR OBTAINING THE SAME
FR3043823B1 (en) METHOD FOR DECAMOUFLING AN OBJECT
FR3019431B1 (en) PRESENCE TRACKING METHOD
FR3018919B1 (en) METHOD FOR SCREENING ERBB2 INHIBITORS AND APPLICATIONS THEREOF
FR3037692B1 (en) BIOMETRIC IDENTIFICATION METHOD
FR3038111B1 (en) IMAGE SEGMENTATION METHOD
FR3019908B1 (en) METHOD OF PROCESSING SEISMIC IMAGES
FR3022168B1 (en) MACHINING INSTALLATION AND ASSOCIATED METHOD
FR3028984B1 (en) METHOD OF SENDING ELECTRONIC RECOMMENDED MAIL
FR3042906B1 (en) METHOD OF SLURING SAMPLES
FR3029311B1 (en) METHOD FOR MANAGING AN ARCHITECTURE AND ASSOCIATED ARCHITECTURE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20191106